All Research
PAPER NLA-20Expert Consensus2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
NLA expert consensus proposing risk-stratified ApoB targets (<90 intermediate, <70 high, <60 mg/dL very-high risk) and concluding ApoB/non-HDL-C stratify ASCVD risk more accurately than LDL-C.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
Journal of Clinical Lipidology
May 2024
03
Structured Methods
- Study Design
- Expert Consensus
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
04
Citations & References
Cite this paper
Unknown authors (2024). Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. Journal of Clinical Lipidology.
Source
Publisher
Journal
Journal of Clinical Lipidology
PHS
671
/ 1000
T3
Longevity Operator
Sample member
Longevity Operator
The Peak Human Score · PHS v1
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation